138 results on '"Goodyer CG"'
Search Results
2. Alu elements in human growth hormone receptor gene 5' untranslated region exons
- Author
-
Goodyer, CG, primary, Zheng, H, additional, and Hendy, GN, additional
- Published
- 2001
- Full Text
- View/download PDF
3. The baboon: a model for the study of primate growth hormone receptor gene expression during development
- Author
-
Zogopoulos, G, primary, Nathanielsz, P, additional, Hendy, GN, additional, and Goodyer, CG, additional
- Published
- 1999
- Full Text
- View/download PDF
4. Role for beta1 integrin and its associated alpha3, alpha5, and alpha6 subunits in development of the human fetal pancreas.
- Author
-
Wang R, Li J, Lyte K, Yashpal NK, Fellows F, Goodyer CG, Wang, Rennian, Li, Jinming, Lyte, Kristina, Yashpal, Nina K, Fellows, Fraser, and Goodyer, Cynthia G
- Abstract
The integrin receptors play a major role in tissue morphogenesis and homeostasis by regulating cell interactions with extracellular matrix proteins. We have examined the expression pattern of integrin subunits in the human fetal pancreas (8-20 weeks fetal age) and the relevance of beta1 integrin function for insulin gene expression and islet cell survival. Its subunits alpha3, alpha5, and alpha6 beta1 integrins are expressed in ductal cells at 8 weeks, before glucagon- and insulin-immunoreactive cells bud off; their levels gradually increase in both ductal cells and islet clusters up to 20 weeks. Colocalization of alpha3, alpha5 and alpha6 beta1 integrins with endocrine cell markers was frequently observed in 8- to 20-week fetal pancreatic cells. When the beta1 integrin receptor was functionally blocked in cultured islet-epithelial clusters with a beta1 immunoneutralizing antibody or following transient beta1 integrin small interfering RNA treatment, there was inhibition of cell adhesion to extracellular matrices, decreased expression of insulin, and increased cell apoptosis. These data offer evidence for dynamic and cell-specific changes in integrin expression during human pancreatic islet neogenesis. They also provide an initial insight into a molecular basis for cell-matrix interactions during islet development and suggest that beta1 integrin plays a vital role in regulating islet cell adhesion, gene expression, and survival. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
5. Biomonitoring of bisphenol A (BPA) and bisphenol analogues in human milk from South Africa and Canada using a modified QuEChERS extraction method.
- Author
-
Chi ZH, Liu L, Zheng J, Tian L, Chevrier J, Bornman R, Obida M, Goodyer CG, Hales BF, and Bayen S
- Subjects
- Humans, South Africa, Benzhydryl Compounds analysis, Canada, Biological Monitoring, Milk, Human chemistry, Phenols
- Abstract
A sensitive modified QuEChERS extraction method was developed to assess the levels of free and conjugated bisphenols (BPs) in human milk collected between 2018 and 2019 from two regions of South Africa (the Limpopo Province Vhembe district, n = 194; Pretoria, n = 193) and Canada (Montreal, n = 207). Total BPA (free and conjugated) and BPS were the predominant bisphenols detected in samples from Vhembe and Pretoria, whereas total BPS was the predominant bisphenol detected in Montreal samples. The levels of total BPA in samples from Vhembe and Pretoria ranged between < MDL-18.61 and
- Published
- 2024
- Full Text
- View/download PDF
6. Food Thermal Labels are a Source of Dietary Exposure to Bisphenol S and Other Color Developers.
- Author
-
Xu Z, Tian L, Liu L, Goodyer CG, Hales BF, and Bayen S
- Subjects
- Animals, European Union, Sulfones, Benzhydryl Compounds, Dietary Exposure, Food
- Abstract
To test the hypothesis that migration from the thermal labels on plastic film packaging is a major source of exposure to bisphenols and alternative color developers in food, we analyzed 140 packaging materials from packaged fresh food purchased in North America. No bisphenol A (BPA) was detected in either the packaging samples or thermal labels. However, significant amounts of bisphenol S (BPS) and alternative color developers (up to 214 μg/cm
2 ) were present in thermal labels; their relative occurrence varied among stores. In a controlled experiment, we wrapped fish in film with a thermal label for 5 days at 4 °C. The fish in contact with the label contained BPS (≤1140 ng/g wet weight [ww]), 4-hydroxyphenyl 4-isoprooxyphenylsulfone (D-8) (≤230 ng/g ww), bis(2-chloroethyl)ether-4,4'-dihydroxydiphenyl sulfone monomer (D-90) (≤3.41 ng/g ww), and/or Pergafast-201 (≤1.87 ng/g ww). The corresponding film samples were then tested using migration cells for 10 days; significantly higher BPS migration was observed systematically from the films with thermal labels compared to plain films. This study provides evidence, for the first time, that BPS and alternative thermal label color developers migrate from packaging materials into food. Further, BPS migration significantly exceeded the European Union Specific Migration Limit (50 ng/g ww), suggesting that further risk assessment studies are warranted.- Published
- 2023
- Full Text
- View/download PDF
7. Characterization of different contaminants and current knowledge for defining chemical mixtures in human milk: A review.
- Author
-
Chi ZH, Goodyer CG, Hales BF, and Bayen S
- Subjects
- Infant, Female, Humans, Environmental Monitoring methods, Breast Feeding, Risk Assessment, Milk, Human chemistry, Pesticides toxicity, Pesticides analysis
- Abstract
Hundreds of xenobiotics, with very diverse origins, have been detected in human milk, including contaminants of emerging concern, personal care products and other current-use substances reflecting lifestyle. The routes of exposure to these chemicals include dermal absorption, ingestion and inhalation. Specific families of chemicals are dominant among human milk monitoring studies (e.g., organochlorine pesticides, bisphenol A, dioxins), even though other understudied families may be equally toxicologically relevant (e.g., food-processing chemicals, current-use plasticizers and flame retardants, mycotoxins). Importantly, the lack of reliable human milk monitoring data for some individual chemicals and, especially, for complex mixtures, is a major factor hindering risk assessment. Non-targeted screening can be used as an effective tool to identify unknown contaminants of concern in human milk. This approach, in combination with novel methods to conduct risk assessments on the chemical mixtures detected in human milk, will assist in elucidating exposures that may have adverse effects on the development of breastfeeding infants., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
8. Exposure of men living in the greater Montreal area to organophosphate esters: Association with hormonal balance and semen quality.
- Author
-
Siddique S, Farhat I, Kubwabo C, Chan P, Goodyer CG, Robaire B, Chevrier J, and Hales BF
- Subjects
- Esters urine, Humans, Male, Organophosphates urine, Phosphates, Seeds, Semen Analysis, Sperm Motility, Testosterone, Flame Retardants
- Abstract
Exposure to organophosphate esters (OPEs) is extensive, yet few studies have investigated their association with hormone levels or semen quality. Here, we studied the association between urinary concentrations of OPEs and their metabolites with hormone levels and semen parameters in men (n = 117) predominantly in the 20-29 years age range who were recruited from the greater Montreal area between 2009 and 2012. Urine, serum, and semen samples were analyzed for OPEs, hormones, and semen quality, respectively. Bis(2-ethylhexyl) phosphate (BEHP), bis(2,4-di-tert-butylphenyl) hydrogen phosphate (B2,4DtBPP), tris(2-chloroisopropyl) phosphate (TCIPP), diphenyl phosphate (DPHP), bis (2-butoxyethyl) phosphate (BBOEP) and di-cresyl phosphate (DCPs) were detected in urine at a frequency ≥ 95%. The highest geometric mean concentration was observed for DPHP (18.54 ng/mL) and the second highest was B2,4DtBPP (6.23 ng/mL). Associations between a doubling in analyte concentrations in urine and hormone levels and semen quality parameters were estimated using multivariable linear regression. B2,4DtBPP levels were positively associated with total T3 (β = 0.09; 95% CI: 0.01, 0.17). DPHP was inversely associated with estradiol (β = -2.56; 95% CI: -5.00, -0.17), and TCIPP was inversely associated with testosterone (β = -0.78; 95% CI: -1.40, -0.17). Concentrations of BCIPP were inversely associated with sperm concentrations (β = -7.76; 95% CI: -14.40, -0.61), progressive motility (β = - 4.98; 95% CI: -8.71, -1.09), and the sperm motility index (β = -9.72; 95% CI: -17.71, -0.96). In contrast, urinary DPHP concentrations were positively associated with the sperm motility (β = 4.37; 95% CI: 0.76, 8.12) and fertility indices (β = 6.64; 95% CI: 1.96, 11.53). Thus, OPE detection rates were high and exposure to several OPEs was associated with altered hormone levels and semen parameters. The possibility that OPEs affect male reproduction warrants further investigation., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
9. Activation of Pancreatic Stellate Cells Is Beneficial for Exocrine but Not Endocrine Cell Differentiation in the Developing Human Pancreas.
- Author
-
Li J, Chen B, Fellows GF, Goodyer CG, and Wang R
- Abstract
Pancreatic stellate cells (PaSCs) are non-endocrine, mesenchymal-like cells that reside within the peri-pancreatic tissue of the rodent and human pancreas. PaSCs regulate extracellular matrix (ECM) turnover in maintaining the integrity of pancreatic tissue architecture. Although there is evidence indicating that PaSCs are involved in islet cell survival and function, its role in islet cell differentiation during human pancreatic development remains unclear. The present study examines the expression pattern and functional role of PaSCs in islet cell differentiation of the developing human pancreas from late 1st to 2nd trimester of pregnancy. The presence of PaSCs in human pancreata (8-22 weeks of fetal age) was characterized by ultrastructural, immunohistological, quantitative RT-PCR and western blotting approaches. Using human fetal PaSCs derived from pancreata at 14-16 weeks, freshly isolated human fetal islet-epithelial cell clusters (hIECCs) were co-cultured with active or inactive PaSCs in vitro . Ultrastructural and immunofluorescence analysis demonstrated a population of PaSCs near ducts and newly formed islets that appeared to make complex cell-cell dendritic-like contacts. A small subset of PaSCs co-localized with pancreatic progenitor-associated transcription factors (PDX1, SOX9, and NKX6-1). PaSCs were highly proliferative, with significantly higher mRNA and protein levels of PaSC markers (desmin, αSMA) during the 1st trimester of pregnancy compared to the 2nd trimester. Isolated human fetal PaSCs were identified by expression of stellate cell markers and ECM. Suppression of PaSC activation, using all-trans retinoic acid (ATRA), resulted in reduced PaSC proliferation and ECM proteins. Co-culture of hIECCs, directly on PaSCs or indirectly using Millicell
® Inserts or using PaSC-conditioned medium, resulted in a reduction the number of insulin+ cells but a significant increase in the number of amylase+ cells. Suppression of PaSC activation or Notch activity during the co-culture resulted in an increase in beta-cell differentiation. This study determined that PaSCs, abundant during the 1st trimester of pancreatic development but decreased in the 2nd trimester, are located near ductal and islet structures. Direct and indirect co-cultures of hIECCs with PaSCs suggest that activation of PaSCs has opposing effects on beta-cell and exocrine cell differentiation during human fetal pancreas development, and that these effects may be dependent on Notch signaling., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Li, Chen, Fellows, Goodyer and Wang.)- Published
- 2021
- Full Text
- View/download PDF
10. Thermal degradation of bisphenol A and bisphenol S in water and fish (cod and basa) fillets.
- Author
-
Tian L, Goodyer CG, Zheng J, and Bayen S
- Subjects
- Animals, Chromatography, High Pressure Liquid, Fishes, Humans, Mass Spectrometry methods, Risk Assessment, Water chemistry, Benzhydryl Compounds analysis, Phenols analysis, Seafood analysis, Sulfones analysis
- Abstract
The thermal degradation of bisphenol A (BPA) and bisphenol S (BPS) was investigated in water and fish (cod, basa) fillets. Ultrasound assisted solvent extraction followed by high performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (HPLC-QTOF-MS) was used to analyze residues in fish. Good instrumental linearity (r
2 > 0.99) and recoveries (83.3-128.4%) were achieved. BPA and BPS did not degrade (1 h; 100 °C) in water (<0.1% degradation) but degraded in fish matrices. The degradation percentage of BPA was 33.0 ± 1.5% and 35.4 ± 1.2% in incurred and spiked cod, respectively; and the degradation percentage of BPS was 34.7 ± 1.7% and 37.5 ± 1.4% in incurred and spiked basa, respectively. The degradation products in spiked samples were different from those in the incurred group under the same conditions. This first study on the thermal degradation of plastic-related chemicals in food using a non-targeted approach will contribute to the refining of food safety risk assessments., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Ltd. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
11. Non-targeted screening of plastic-related chemicals in food collected in Montreal, Canada.
- Author
-
Tian L, Zheng J, Goodyer CG, and Bayen S
- Subjects
- Animals, Benzhydryl Compounds analysis, Bread analysis, Canada, Chickens, Chromatography, High Pressure Liquid, Fish Products analysis, Fishes, Limit of Detection, Meat analysis, Phenols analysis, Tandem Mass Spectrometry methods, Vegetables chemistry, Food Contamination analysis, Plastics analysis
- Abstract
A non-targeted screening method based on ultrasound-assisted extraction followed by high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (HPLC-QTOF-MS) was developed to screen for the presence of plastic-related chemicals (PRCs) in different types of food (fish, chicken, canned tuna, leafy vegetables, bread and butter). Eleven bisphenols were used as targeted compounds. Instrument linearity (r
2 ≥0.98), inter-day precision (RSD ≤9.0%) as well as method detection limits (MDLs below 3.6 ng g-1 ) were satisfactory. Recoveries of the eleven bisphenols ranged from 76% to 122% among the different food matrices. The method was applied to food collected from Montreal, Canada in 2017-2018. The non-targeted screening approach identified a range of contaminants in different food matrices, including BPA, BPS, bis(2-ethylhexyl) adipate, dibutyl adipate, hexadecyl methacrylate and Irganox®1076. Further research is suggested to investigate the concentration of these PRCs, the consumption habits of average and specific populations and the potential routes of contamination., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Ltd. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
12. Sex-specific effects of a microsatellite polymorphism on human growth hormone receptor gene expression.
- Author
-
Dias C, Elzein S, Sladek R, and Goodyer CG
- Subjects
- CCAAT-Enhancer-Binding Protein-beta genetics, Cell Line, Female, Gene Expression Regulation, HEK293 Cells, Humans, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Insulin-Like Growth Factor I genetics, Male, Proto-Oncogene Proteins c-bcl-2 genetics, Sex Characteristics, Carrier Proteins genetics, Dwarfism genetics, Microsatellite Repeats, Promoter Regions, Genetic
- Abstract
Growth hormone (GH) binds to its specific receptor (GHR) at the surface of target cells activating multiple signaling pathways implicated in growth and metabolism. Dysregulation of GHRs leads to pathophysiological states that most commonly affect stature. We previously showed the association of a polymorphic (n = 15-37) GT microsatellite in the human GHR gene promoter with short stature in a sex-specific manner. In the present study we evaluated the functional relevance of this polymorphism in regulating GHR expression. Using luciferase reporter assays, we found that the GT repeat had a significant cis regulatory effect in response to HIF1α and a potential repressor role following C/EBPβ stimulation. Using a digital PCR application to measure allelic imbalance (AI), we showed a high prevalence of AI (∼76%) at the GHR locus in lymphoblastoid cell lines (LCLs), with a significantly higher degree of imbalance in LCLs derived from males. Examination of expression of GHR as well as other members of the GH-IGF1 axis in the LCLs revealed significant associations of GHR, IGF1 and BCL2 expression with GT genotype in a sex-specific manner. Our results suggest that this GT microsatellite exerts both cis and trans effects in a sex-specific context, revealing a new mechanism by which GHR gene expression is regulated., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
13. Exposure to polybrominated diphenyl ethers and phthalates in healthy men living in the greater Montreal area: A study of hormonal balance and semen quality.
- Author
-
Albert O, Huang JY, Aleksa K, Hales BF, Goodyer CG, Robaire B, Chevrier J, and Chan P
- Subjects
- Humans, Male, Quebec, Semen Analysis, Environmental Exposure analysis, Halogenated Diphenyl Ethers blood, Phthalic Acids blood, Spermatozoa physiology, Testosterone blood, Thyrotropin blood
- Abstract
Studies investigating the associations between exposure of young men to polybrominated diphenyl ethers (PBDEs) or phthalates and hormone levels or semen quality have produced inconsistent results. Our goal was to investigate the association of exposure to PBDEs or phthalate metabolites with changes in markers of thyroid (TSH, free T3 and free T4) and reproductive function (sperm concentrations, motility, and quality; serum LH and testosterone) in 153 healthy young men from the greater Montreal area. Using covariate-adjusted models, we found that each 10-fold increase in BDE-47 was associated with lower TSH levels (-17.3%; 95% CI: -31.5, 0.0; p = 0.05). BDE-47 exposure was also associated with a decrease in sperm concentration (-19.7%; 95% CI: -36.8; 2.0; p = 0.07) and motility (-25.5%; 95% CI: -44.5, 0.1; p = 0.05). Trends towards decreases in these parameters were also observed in association with exposure to BDE-100 and the sum of BDE-47, -99, and -100 (∑
3 BDEs). These associations were not accompanied by effects on sperm chromatin quality, as assessed with the HT-COMET assay. There were no substantial associations between urinary phthalate metabolite concentrations, either individually or grouped by molecular weight or parent compound, and sperm quality parameters; however, there was a positive association between elevated MECCP and free T4 (0.98; 95% CI: 0.02, 1.94; p = 0.05). Inverse associations between BDE-47 and ∑3 BDEs and free T3 and positive associations between MEHP and free T3 were stronger among individuals with BMI ≥ 25, suggesting that weight status may modify the effects of these endocrine disrupting chemicals., (Copyright © 2018 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
14. Erratum: "A Case-Control Study of Maternal Polybrominated Diphenyl Ether (PBDE) Exposure and Cryptorchidism in Canadian Populations".
- Author
-
Goodyer CG, Poon S, Aleksa K, Hou L, Atehortua V, Carnevale A, Koren G, Jednak R, Emil S, Bagli D, Dave S, Hales BF, and Chevrier J
- Abstract
[This corrects the article DOI: 10.1289/EHP522.].
- Published
- 2018
- Full Text
- View/download PDF
15. Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature.
- Author
-
Dias C, Giordano M, Frechette R, Bellone S, Polychronakos C, Legault L, Deal CL, and Goodyer CG
- Subjects
- Adolescent, Alleles, Base Sequence, Case-Control Studies, Child, Child, Preschool, Cohort Studies, Dwarfism metabolism, Female, Gene Expression, Gene Frequency, Haplotypes, Human Growth Hormone metabolism, Humans, Male, Phenotype, Receptors, Somatotropin metabolism, Risk, Dwarfism genetics, Human Growth Hormone genetics, Microsatellite Repeats, Polymorphism, Single Nucleotide, Receptors, Somatotropin genetics
- Abstract
GH plays an essential role in the growing child by binding to the growth hormone receptor (GHR) on target cells and regulating multiple growth promoting and metabolic effects. Mutations in the GHR gene coding regions result in GH insensitivity (dwarfism) due to a dysfunctional receptor protein. However, children with idiopathic short stature (ISS) show growth impairment without GH or GHR defects. We hypothesized that decreased expression of the GHR gene may be involved. To test this, we investigated whether common genetic variants (microsatellites, SNPs) in regulatory regions of the GHR gene region were associated with the ISS phenotype. Genotyping of a GT-repeat microsatellite in the GHR 5'UTR in a Montreal ISS cohort (n = 37 ISS, n = 105 controls) revealed that the incidence of the long/short (L/S) genotype was 3.3× higher in ISS children than controls (P = 0.04, OR = 3.85). In an Italian replication cohort (n = 143 ISS, n = 282 controls), the medium/short (M/S) genotype was 1.9× more frequent in the male ISS than controls (P = 0.017, OR = 2.26). In both ISS cohorts, logistic regression analysis of 27 SNPs showed an association of ISS with rs4292454, while haplotype analysis revealed specific risk haplotypes in the 3' haploblocks. In contrast, there were no differences in GT genotype frequencies in a cohort of short stature (SS) adults versus controls (CARTaGENE: n = 168 SS, n = 207 controls) and the risk haplotype in the SS cohort was located in the most 5' haploblock. These data suggest that the variants identified are potentially genetic markers specifically associated with the ISS phenotype., (© 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.)
- Published
- 2017
- Full Text
- View/download PDF
16. A Case-Control Study of Maternal Polybrominated Diphenyl Ether (PBDE) Exposure and Cryptorchidism in Canadian Populations.
- Author
-
Goodyer CG, Poon S, Aleksa K, Hou L, Atehortua V, Carnevale A, Koren G, Jednak R, Emil S, Bagli D, Dave S, Hales BF, and Chevrier J
- Subjects
- Adult, Canada epidemiology, Case-Control Studies, Endocrine Disruptors adverse effects, Endocrine Disruptors analysis, Environmental Exposure, Female, Flame Retardants analysis, Halogenated Diphenyl Ethers analysis, Humans, Infant, Male, Pregnancy, Cryptorchidism epidemiology, Flame Retardants adverse effects, Hair chemistry, Halogenated Diphenyl Ethers adverse effects, Maternal Exposure
- Abstract
Background: Polybrominated diphenyl ethers (PBDEs) are flame retardants found in North American household products during the past four decades. These chemicals leach out in dust as products age, exposing individuals daily through inhalation and ingestion. Animal studies suggest that PBDEs disrupt sex hormones and adversely affect development of the reproductive system., Objectives: In the present study, we examined whether there is a link between maternal hair PBDE concentrations and the risk of cryptorchidism (undescended testes) in male infants; testis descent is known to be dependent on androgens., Methods: Full-term male infants were recruited through clinics in Montreal, Toronto, and London, Canada. Boys with cryptorchidism at 3-18 months of age ( n =137) were identified by pediatric urologists and surgeons; similar-aged controls ( n =158) had no genitourinary abnormalities as assessed by pediatricians. Eight BDE congeners (BDE-28, -47, -99, -100, -153, -154, -183, -209) were measured by GC-MS (gas chromatography-mass spectrometry) in maternal hair samples collected at the time of recruitment., Results: The ∑PBDE geometric mean for maternal hair was 45.35 pg/mg for controls and 50.27 pg/mg for cases; the concentrations of three BDEs (BDE-99, -100, and -154) were significantly higher in cases than controls in unadjusted models. In adjusted models, every 10-fold increase in the concentration of maternal hair BDE-99 [OR=2.53 (95% CI: 1.29, 4.95) or BDE-100 [OR=2.45 (95% CI: 1.31, 4.56)] was associated with more than a doubling in the risk of cryptorchidism. BDE-154 [OR=1.88 (95% CI: 1.08, 3.28) was also significant., Conclusions: Our results suggest that maternal exposure to BDE-99, -100, and -154 may be associated with abnormal migration of testes in the male fetus. This may be due to the anti-androgenic properties of the PBDEs. https://doi.org/10.1289/EHP522.
- Published
- 2017
- Full Text
- View/download PDF
17. Role of DNA methylation in expression control of the IKZF3-GSDMA region in human epithelial cells.
- Author
-
Moussette S, Al Tuwaijri A, Kohan-Ghadr HR, Elzein S, Farias R, Bérubé J, Ho B, Laprise C, Goodyer CG, Rousseau S, and Naumova AK
- Subjects
- Alleles, Amino Acid Motifs, Azacitidine chemistry, Binding Sites, Cell Line, Egg Proteins genetics, Gene Expression Profiling, Gene Expression Regulation, Genetic Predisposition to Disease, Genome-Wide Association Study, Genotype, HEK293 Cells, Humans, MCF-7 Cells, Membrane Proteins genetics, Phenotype, Polymorphism, Single Nucleotide, Promoter Regions, Genetic, Up-Regulation, DNA Methylation, Epithelial Cells metabolism, Ikaros Transcription Factor genetics, Neoplasm Proteins genetics
- Abstract
Chromosomal region 17q12-q21 is associated with asthma and harbors regulatory polymorphisms that influence expression levels of all five protein-coding genes in the region: IKAROS family zinc finger 3 (Aiolos) (IKZF3), zona pellucida binding protein 2 (ZPBP2), ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3), and gasdermins A and B (GSDMA, GSDMB). Furthermore, DNA methylation in this region has been implicated as a potential modifier of the genetic risk of asthma development. To further characterize the effect of DNA methylation, we examined the impact of treatment with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) that causes DNA demethylation, on expression and promoter methylation of the five 17q12-q21 genes in the human airway epithelium cell line NuLi-1, embryonic kidney epithelium cell line 293T and human adenocarcinoma cell line MCF-7. 5-aza-dC treatment led to upregulation of expression of GSDMA in all three cell lines. ZPBP2 was upregulated in NuLi-1, but remained repressed in 293T and MCF-7 cells, whereas ORMDL3 was upregulated in 293T and MCF-7 cells, but not NuLi-1. Upregulation of ZPBP2 and GSDMA was accompanied by a decrease in promoter methylation. Moreover, 5-aza-dC treatment modified allelic expression of ZPBP2 and ORMDL3 suggesting that different alleles may respond differently to treatment. We also identified a polymorphic CTCF-binding site in intron 1 of ORMDL3 carrying a CG SNP rs4065275 and determined its methylation level. The site's methylation was unaffected by 5-aza-dC treatment in NuLi-1 cells. We conclude that modest changes (8-13%) in promoter methylation levels of ZPBP2 and GSDMA may cause substantial changes in RNA levels and that allelic expression of ZPBP2 and ORMDL3 is mediated by DNA methylation.
- Published
- 2017
- Full Text
- View/download PDF
18. Pregnant Women's perceptions of exposure to brominated flame retardants.
- Author
-
Lane A, Goodyer CG, Rab F, Ashley JM, Sharma S, Hodgson A, and Nisker J
- Subjects
- Consumer Product Safety legislation & jurisprudence, Female, Health Promotion legislation & jurisprudence, Household Products standards, Household Products toxicity, Humans, Legislation as Topic, Maternal Exposure prevention & control, Needs Assessment, Ontario epidemiology, Physician's Role, Pregnancy, Prenatal Exposure Delayed Effects epidemiology, Prenatal Exposure Delayed Effects prevention & control, Qualitative Research, Risk, Workforce, Endocrine Disruptors toxicity, Flame Retardants toxicity, Halogenated Diphenyl Ethers toxicity, Health Knowledge, Attitudes, Practice, Maternal Exposure adverse effects
- Abstract
Background: Recent media reports on human studies associating brominated flame retardants (BFRs) in household products in pregnancy with urogenital anomalies in boys and endocrine disruption in both sexes. We sought to explore the perceptions of pregnant women of brominated flame retardant (BFR) exposure, in light of recent media reports on the adverse health effects of BFR exposure prenatally., Methods: Pregnant women were recruited for interviews through posters and pamphlets in prenatal clinics, prenatal fairs and community centres. Interviews were audiotaped and transcribed verbatim for Charmaz-based qualitative analysis supported by NVIVO 10™., Results: Theoretical sufficiency was reached after analyzing the interviews of 23 pregnant women. Themes co-constructed were: I-Lack of Awareness of BFRs; II-Factors Influencing BFR Exposure; III-Responsibility; IV-Informed Choice. Almost all participants felt it was difficult to make informed choices to avoid BFRs, and wanted communication from clinicians and regulation from governments regarding decreasing BFR exposure., Conclusion: Pregnant women in Canada may be unaware of the potential risks of exposure to BFRs. Professional organizations and governments should further study risk associated with BFR exposure in pregnancy and provide educational materials for pregnant women and clinicians regarding BFR exposure.
- Published
- 2016
- Full Text
- View/download PDF
19. Hair as a biomarker of systemic exposure to polybrominated diphenyl ethers.
- Author
-
Poon S, Wade MG, Aleksa K, Rawn DF, Carnevale A, Gaertner DW, Sadler A, Breton F, Koren G, Ernest SR, Lalancette C, Robaire B, Hales BF, and Goodyer CG
- Subjects
- Adult, Aged, Animals, Diet, Dust, Female, Flame Retardants pharmacokinetics, Gas Chromatography-Mass Spectrometry, Halogenated Diphenyl Ethers blood, Halogenated Diphenyl Ethers pharmacokinetics, Humans, Liver chemistry, Liver drug effects, Male, Middle Aged, Polybrominated Biphenyls analysis, Rats, Rats, Sprague-Dawley, Tissue Distribution, Young Adult, Biomarkers analysis, Environmental Exposure analysis, Flame Retardants analysis, Hair chemistry, Halogenated Diphenyl Ethers analysis
- Abstract
The efficacy of using hair as a biomarker for exposure to polybrominated diphenyl ether (PBDE) flame retardants was assessed in humans and an animal model. Paired human hair and serum samples were obtained from adult men and women (n = 50). In parallel, hair, serum, liver, and fat were collected from adult male Sprague-Dawley rats exposed to increasing doses of the PBDE mixture found in house dust for 70 days via the diet. All samples were analyzed by GC-MS for eight common PBDEs: BDE-28, -47, -99, -100, -153, -154, -183, and -209. Paired human hair and serum samples had five congeners (BDE-28, -47, -99, -100, and -154) with significant individual correlations (0.345-0.566). In rat samples, BDE-28 and BDE-183 were frequently below the level of detection. Significant correlations were observed for BDE-47, -99, -100, -153, -154, and -209 in rat hair, serum, liver, and fat across doses, with r values ranging from 0.803 to 0.988; weaker correlations were observed between hair and other tissues when data from the lowest dose group or for BDE-209 were analyzed. Thus, human and rat hair PBDE measurements correlate strongly with those in alternative matrices, validating the use of hair as a noninvasive biomarker of long-term PBDE exposure.
- Published
- 2014
- Full Text
- View/download PDF
20. Regulation of human growth hormone receptor expression by microRNAs.
- Author
-
Elzein S and Goodyer CG
- Subjects
- 3' Untranslated Regions, Binding Sites, Cell Differentiation, Cell Line, Cell Line, Tumor, Cloning, Molecular, Gene Expression Regulation, HEK293 Cells, Humans, MCF-7 Cells, Mutagenesis, Polymerase Chain Reaction, RNA, Messenger metabolism, Gene Expression Regulation, Neoplastic, Membrane Proteins metabolism, MicroRNAs metabolism
- Abstract
Human GH binds to its receptor (GHR) on target cells and activates multiple intracellular pathways, leading to changes in gene expression, differentiation, and metabolism. GHR deficiency is associated with growth and metabolic disorders whereas increased GHR expression has been reported in certain cancers, suggesting that the GHR gene requires tight controls. Several regulatory mechanisms have been found within its 5'-untranslated region (UTR) promoter and coding regions. However, the 3'-UTR has not been previously examined. MicroRNAs (miRNAs) are small (19-22 nucleotides) noncoding RNAs that downregulate gene expression mainly through targeting the 3'-UTR of mRNAs and enhancing their degradation or inhibiting translation. In the present study, we investigated whether miRNAs regulate GHR expression. To define putative miRNA binding sites in the GHR 3'-UTR, we used multiple in silico prediction tools, analyzed conservation across species and the presence of parallel sites in GH/IGF axis-related genes, and searched for reports linking miRNAs to GHR-related physiological or pathophysiological activities. To test prioritized sites, we cotransfected a wild-type GHR 3'-UTR luciferase reporter vector as well as miRNA binding site mutants into HEK293 cells with miRNA mimics. Furthermore, we tested whether the miRNAs altered endogenous GHR mRNA and protein levels in HEK293 cells and in 2 cancer cell lines (MCF7 and LNCaP). Our experiments have identified miRNA (miR)-129-5p, miR-142-3p, miR-202, and miR-16 as potent inhibitors of human GHR expression in normal (HEK293) and cancer (MCF7 and LNCaP) cells. This study paves the way for the development of miRNA inhibitors as therapeutic agents in GH/GHR-related pathophysiologies, including cancer.
- Published
- 2014
- Full Text
- View/download PDF
21. Investigating the use of hair to assess polybrominated diphenyl ether exposure retrospectively.
- Author
-
Carnevale A, Aleksa K, Goodyer CG, and Koren G
- Subjects
- Adult, Artifacts, Diet, Female, Flame Retardants analysis, Gas Chromatography-Mass Spectrometry, Hair Dyes, Humans, Reproducibility of Results, Retrospective Studies, Young Adult, Environmental Exposure analysis, Environmental Pollutants analysis, Hair chemistry, Halogenated Diphenyl Ethers analysis
- Abstract
Background: Polybrominated diphenyl ethers (PBDEs) are chemicals that are added to a variety of consumer products as flame-retardants and have been classified as emerging endocrine disruptors. They are persistent and have been detected in humans. Previous studies have suggested that hair is a suitable matrix for examining human exposure to organic pollutants such as PBDEs. It is believed that the majority of exposure is from our indoor environment. The aim of this study was to investigate the changes in PBDE patterns and levels along the hair shaft, by using segmental analysis to retrospectively assess long-term exposure over a 1-year period., Methods: Questionnaires and hair samples from 65 women were collected at the Hospital for Sick Children, in Toronto, as part of a larger study. To assess long-term stability, hair samples were separated into 4- and 3-cm segments representing a 1-year period. Hair segments were analyzed for levels of 8 PBDE congeners, BDE-28, BDE-47, BDE-99, BDE-100, BDE-153, BDE-154, BDE-183, and BDE-209 on gas chromatography-mass spectrometry (MS). A Friedman test was used to detect the differences in exposure among segments, and factors such as dietary habits, hair care routine, and site of residence were investigated to determine if they might affect hair levels., Results: A significant increase (P < 0.0001) in total PBDEs was seen among segments moving from proximal (root end) to distal along the hair shaft (median in pg/mg): first (33.3), second (43.0), third (61.6), and fourth (75.5) segments. Significantly lower levels of PBDEs were observed in artificially colored hair samples (P = 0.032), and a significant increase in PBDE levels was observed in women who consumed meat on a daily basis as opposed to weekly consumption (P = 0.040)., Conclusions: The increase in PBDEs along the hair shaft suggests that hair PBDEs may be influenced by diet and artificial coloring. More work is needed to validate the use of PBDEs in hair as a biomarker of long-term exposure.
- Published
- 2014
- Full Text
- View/download PDF
22. Aldehyde dehydrogenase 1 activity in the developing human pancreas modulates retinoic acid signalling in mediating islet differentiation and survival.
- Author
-
Li J, Feng ZC, Yeung FS, Wong MR, Oakie A, Fellows GF, Goodyer CG, Hess DA, and Wang R
- Subjects
- Aldehyde Dehydrogenase 1 Family, Blotting, Western, Female, Fluorescent Antibody Technique, Gene Expression Regulation, Developmental, Humans, Islets of Langerhans embryology, Islets of Langerhans enzymology, Isoenzymes genetics, Pregnancy, Retinal Dehydrogenase genetics, Isoenzymes metabolism, Pancreas embryology, Pancreas enzymology, Retinal Dehydrogenase metabolism, Tretinoin metabolism
- Abstract
Aims/hypothesis: Aldehyde dehydrogenase 1 (ALDH1), a human stem-cell marker, is an enzyme responsible for converting retinaldehydes to retinoic acids (RAs) to modulate cell differentiation. However, data on expression levels and functional roles of ALDH1 during human fetal pancreatic development are limited. The focus of this study was to characterise ALDH1 expression patterns and to determine its functional role in islet cell differentiation., Methods: The presence of ALDH1 in the human fetal pancreas (8-22 weeks) was characterised by microarray, quantitative RT-PCR, western blotting and immunohistological approaches. Isolated human fetal islet-epithelial cell clusters were treated with ALDH1 inhibitors, retinoic acid receptor (RAR) agonists and ALDH1A1 small interfering (si)RNA., Results: In the developing human pancreatic cells, high ALDH1 activity frequently co-localised with key stem-cell markers as well as endocrine transcription factors. A high level of ALDH1 was expressed in newly differentiated insulin(+) cells and this decreased as development progressed. Pharmacological inhibition of ALDH1 activity in human fetal islet-epithelial cell clusters resulted in reduced endocrine cell differentiation and increased cell apoptosis, and was reversed with co-treatment of RAR/RXR agonists. Furthermore, siRNA knockdown of ALDH1A1 significantly decreased RAR expression and induced cell apoptosis via suppression of the phosphoinositide 3-kinase (PI3K) pathway and activation of caspase signals., Conclusions/interpretation: Our findings indicate that ALDH1(+) cells represent a pool of endocrine precursors in the developing human pancreas and that ALDH1 activity is required during endocrine cell differentiation. Inhibition of ALDH1-mediated retinoid signalling impairs human fetal islet cell differentiation and survival.
- Published
- 2014
- Full Text
- View/download PDF
23. Hexabromocyclododecane concentrations in Canadian human fetal liver and placental tissues.
- Author
-
Rawn DF, Gaertner DW, Weber D, Curran IH, Cooke GM, and Goodyer CG
- Subjects
- Adult, Analysis of Variance, Chromatography, Liquid, Environmental Monitoring methods, Female, Flame Retardants metabolism, Humans, Hydrocarbons, Brominated metabolism, Pregnancy, Quebec, Tandem Mass Spectrometry, Environmental Monitoring statistics & numerical data, Fetus metabolism, Flame Retardants pharmacokinetics, Hydrocarbons, Brominated pharmacokinetics, Liver metabolism, Placenta metabolism
- Abstract
Detectable concentrations of the flame retardant hexabromocyclododecane (HBCD) have been reported in human tissues worldwide, but investigations to determine fetal exposure to this brominated flame retardant are lacking. This study was undertaken to determine the concentrations of α-, β- and γ-HBCD in human tissues (fetal liver and placenta) from Canada. Tissue samples were collected over a thirteen year period following elective pregnancy terminations in Montreal, Quebec, Canada. Samples were extracted using homogenisation with solvent, cleaned up using adsorption chromatography and analysis was performed with liquid chromatography-tandem mass spectrometry. Total HBCD concentrations ranged from below the limit of detection (
- Published
- 2014
- Full Text
- View/download PDF
24. Ultrastructural and immunohistochemical analysis of the 8-20 week human fetal pancreas.
- Author
-
Riopel M, Li J, Fellows GF, Goodyer CG, and Wang R
- Subjects
- Endocrine Cells ultrastructure, Fluorescent Antibody Technique, Gestational Age, Glycogen analysis, Humans, Immunohistochemistry, Insulin analysis, Microscopy, Electron, Scanning, Microscopy, Electron, Scanning Transmission, Pancreas chemistry, Pancreas ultrastructure, Secretory Vesicles ultrastructure, Pancreas embryology
- Abstract
Development of the human pancreas is well-known to involve tightly controlled differentiation of pancreatic precursors to mature cells that express endocrine- or exocrine-specific protein products. However, details of human pancreatic development at the ultrastructural level are limited. The present study analyzed 8-20 week fetal age human pancreata using scanning and transmission electron microscopy (TEM), TEM immunogold and double or triple immunofluorescence staining. Primary organization of islets and acini occurred during the developmental period examined. Differentiating endocrine and exocrine cells developed from the ductal tubules and subsequently formed isolated small clusters. Extracellular matrix fibers and proteins accumulated around newly differentiated cells during their migration and cluster formation. Glycogen expression was robust in ductal cells of the pancreas from 8-15 weeks of fetal age; however, this became markedly reduced at 20 weeks, with a concomitant increase in acinar cell glycogen content. Insulin secretory granules transformed from being dense and round at 8 weeks to distinct geometric (multilobular, crystalline) structures by 14-20 weeks. Initially many of the differentiating endocrine cells were multihormonal and contained polyhormonal granules; by 20 weeks, monohormonal cells were in the majority. Interestingly, certain secretory granules in the early human fetal pancreatic cells showed positivity for both exocrine (amylase) and endocrine proteins. This combined ultrastructural and immunohistochemical study showed that, during early developmental stages, the human pancreas contains differentiating epithelial cells that associate closely with the extracellular matrix, have dynamic glycogen expression patterns and contain polyhormonal as well as mixed endocrine/exocrine granules.
- Published
- 2014
- Full Text
- View/download PDF
25. Expression and activation of caspase-6 in human fetal and adult tissues.
- Author
-
Godefroy N, Foveau B, Albrecht S, Goodyer CG, and LeBlanc AC
- Subjects
- Adult, Apoptosis, Caspase 1 metabolism, Enzyme Activation, Female, Fetus cytology, Humans, Organ Specificity, Protein Subunits metabolism, Caspase 6 metabolism, Fetus enzymology, Gene Expression Regulation, Enzymologic
- Abstract
Caspase-6 is an effector caspase that has not been investigated thoroughly despite the fact that Caspase-6 is strongly activated in Alzheimer disease brains. To understand the full physiological impact of Caspase-6 in humans, we investigated Caspase-6 expression. We performed western blot analyses to detect the pro-Caspase-6 and its active p20 subunit in fetal and adult lung, kidney, brain, spleen, muscle, stomach, colon, heart, liver, skin, and adrenals tissues. The levels were semi-quantitated by densitometry. The results show a ubiquitous expression of Caspase-6 in most fetal tissues with the lowest levels in the brain and the highest levels in the gastrointestinal system. Caspase-6 active p20 subunits were only detected in fetal stomach. Immunohistochemical analysis of a human fetal embryo showed active Caspase-6 positive apoptotic cells in the dorsal root ganglion, liver, lung, kidney, ovary, skeletal muscle and the intestine. In the adult tissues, the levels of Caspase-6 were lower than in fetal tissues but remained high in the colon, stomach, lung, kidney and liver. Immunohistological analyses revealed that active Caspase-6 was abundant in goblet cells and epithelial cells sloughing off the intestinal lining of the adult colon. These results suggest that Caspase-6 is likely important in most tissues during early development but is less involved in adult tissues. The low levels of Caspase-6 in fetal and adult brain indicate that increased expression as observed in Alzheimer Disease is a pathological condition. Lastly, the high levels of Caspase-6 in the gastrointestinal system indicate a potential specific function of Caspase-6 in these tissues.
- Published
- 2013
- Full Text
- View/download PDF
26. Bisphenol A in human placental and fetal liver tissues collected from Greater Montreal area (Quebec) during 1998-2008.
- Author
-
Cao XL, Zhang J, Goodyer CG, Hayward S, Cooke GM, and Curran IH
- Subjects
- Benzhydryl Compounds, Environmental Pollutants pharmacokinetics, Female, Fetus metabolism, Humans, Liver metabolism, Maternal-Fetal Exchange, Phenols pharmacokinetics, Placenta metabolism, Pregnancy, Quebec, Environmental Pollutants analysis, Fetus chemistry, Liver chemistry, Phenols analysis, Placenta chemistry
- Abstract
In this study, the presence of bisphenol A (BPA) in human placental and fetal liver samples collected from 1998 to 2008 was investigated to provide a more detailed analysis of the transfer of BPA across the placenta and fetal exposure to BPA. The average concentrations in placental samples were 12.6 ng g(-1) for free BPA, 17.2 ng g(-1) for BPA-glu, and 30.2 ng g(-1) for total BPA. The highest concentrations in placental samples were 165 ng g(-1) for free BPA, 178 ng g(-1) for BPA-glu, and 280 ng g(-1) for total BPA. Samples with higher levels of BPA-glu had higher levels of free BPA in general. Fetal age was observed to have a significant effect on BPA-glu levels in placental samples, but not on free or total BPA. The percentages of free BPA relative to total BPA for the placental samples varied considerably from 4.2% to 100%, suggesting that the ability of maternal liver and/or the placenta to conjugate BPA is highly variable during early to mid-gestation. The average concentrations in fetal liver samples were 9.02 ng g(-1) for free BPA, 19.1 ng g(-1) for BPA-glu, and 25.8 ng g(-1) for total BPA. The highest concentrations in fetal liver samples were 37.7 ng g(-1) for free BPA, 93.9 ng g(-1) for BPA-glu, and 123 ng g(-1) for total BPA. The percentages of free BPA level relative to total BPA for all fetal liver samples varied from 12.4% to 99.1%, indicating extensive variability in the ability of the human feto-placental unit to glucuronidate BPA., (Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
27. SOX9 regulates endocrine cell differentiation during human fetal pancreas development.
- Author
-
McDonald E, Li J, Krishnamurthy M, Fellows GF, Goodyer CG, and Wang R
- Subjects
- Basic Helix-Loop-Helix Transcription Factors metabolism, Cell Differentiation physiology, Gene Expression Regulation, Developmental, Gene Knockdown Techniques, Glycogen Synthase Kinase 3 metabolism, Glycogen Synthase Kinase 3 beta, Homeobox Protein Nkx-2.2, Homeodomain Proteins, Humans, Islets of Langerhans cytology, Islets of Langerhans metabolism, Nerve Tissue Proteins metabolism, Nuclear Proteins, Oncogene Protein v-akt metabolism, Pancreas cytology, RNA, Messenger biosynthesis, RNA, Messenger genetics, SOX9 Transcription Factor genetics, SOX9 Transcription Factor metabolism, Signal Transduction, Transcription Factors, Transfection, Islets of Langerhans embryology, Pancreas embryology, SOX9 Transcription Factor biosynthesis
- Abstract
The transition of pancreatic progenitor cells to mature endocrine cells is regulated by the sequential activation and interaction of several transcription factors. In mice, the transcription factor Sox9 has been shown to support endocrine cell differentiation. However, the functional role of SOX9 during pancreas development in the human has yet to be determined. The present study was to characterize SOX9 expression during human fetal pancreas development and examine its functional role by transfection with SOX9 siRNA or SOX9 expression vectors. Here we report that SOX9 was most frequently expressed in PDX1(+) cells (60-83%) and least in mature endocrine cells (<1-14%). The proliferation of SOX9(+) cells was significantly higher at 8-10 weeks than at 14-21 weeks (p<0.05) or 20-21 weeks (p<0.01). SOX9 frequently co-localized with FOXA2, NGN3 and transcription factors linked to NGN3 (NKX2.2, NKX6.1, PAX6). siRNA knockdown of SOX9 significantly decreased islet-epithelial cell proliferation, NGN3, NKX6.1, PAX6 and INS mRNA levels and the number of NGN3(+) and insulin(+) cells (p<0.05) while increasing GCG mRNA and glucagon(+) cells (p<0.05). Examination of SOX9 associated signaling pathways revealed a decrease in phospho-Akt (p<0.01), phospho-GSK3β (p<0.01) and cyclin D1 (p<0.01) with a decrease in nuclear β-catenin(+) (p<0.05) cells following SOX9 siRNA knockdown. In contrast, over-expression of SOX9 significantly increased the number of islet cells proliferating, NGN3, NKX6.1, PAX6 and INS mRNA levels, the phospho-Akt/GSK3β cascade and the number of insulin(+) cells. Our results demonstrated that SOX9 is important for the expression of NGN3 and molecular markers of endocrine cell differentiation in the human fetal pancreas., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
28. Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women.
- Author
-
Erman A, Veilleux A, Tchernof A, and Goodyer CG
- Subjects
- Adult, Biomarkers metabolism, Cohort Studies, Female, Gene Expression Regulation, Humans, Membrane Proteins genetics, Middle Aged, Obesity genetics, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Thinness metabolism, Adipocytes metabolism, Body Mass Index, Membrane Proteins metabolism, Obesity metabolism, Omentum metabolism, Subcutaneous Fat metabolism
- Abstract
Objectives: Growth hormone (GH)-deficient individuals display increased adiposity that can be effectively reduced by GH therapy because of GH's lipolytic effects. However, similar GH treatments of individuals with idiopathic obesity (not associated with an endocrinopathy/syndrome) have had little success. We hypothesized that this form of obesity may be associated with GH resistance at the level of the adipocyte because of reduced GH receptor (GHR) expression., Subjects and Methods: We studied GHR expression in omental and subcutaneous fat tissues from a cohort of 55 women ranging from lean to obese by various adiposity parameters. mRNA levels of total GHR and the dominant-negative truncated GHR(1-279) (trGHR) form were assayed by quantitative reverse transcriptase-PCR. Associations between adiposity measures and GHR levels as well as trGHR/GHR ratios were analyzed., Results: Total GHR mRNA expression was 2-3-fold lower in omental as well as subcutaneous adipose tissues of obese compared with lean women (P ≤ 0.05-0.001). Lean individuals expressed higher GHR mRNA levels in omental fat compared with subcutaneous (P ≤ 0.01); in obese women, this depot-specific difference was lost. Omental and subcutaneous adipose GHR mRNA levels displayed significant negative correlations with a spectrum of indicators of obesity while, in subcutaneous fat, there was a significantly higher trGHR/GHR ratio with increasing adiposity (P ≤ 0.05)., Conclusion: These results support our hypothesis that, with obesity, there is lower GHR expression in the adipocyte, and suggest one possible explanation why GH supplementation is not an effective treatment for individuals with idiopathic obesity.
- Published
- 2011
- Full Text
- View/download PDF
29. Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors.
- Author
-
Erman A, Wabitsch M, and Goodyer CG
- Subjects
- Arrhythmias, Cardiac pathology, Biomarkers metabolism, Chromatin Immunoprecipitation, Down-Regulation, Genetic Diseases, X-Linked, Gigantism pathology, Glucocorticoids genetics, HEK293 Cells, Heart Defects, Congenital pathology, Humans, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Intellectual Disability pathology, Membrane Proteins genetics, Mutagenesis, Site-Directed, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Transcription, Genetic, Tumor Necrosis Factor-alpha genetics, Adipocytes metabolism, Adipose Tissue metabolism, Arrhythmias, Cardiac metabolism, Gigantism metabolism, Glucocorticoids metabolism, Heart Defects, Congenital metabolism, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Intellectual Disability metabolism, Membrane Proteins metabolism, Obesity metabolism, Tumor Necrosis Factor-alpha metabolism
- Abstract
Background and Methods: In our previous analyses, we found significantly lower levels of growth hormone receptor (GHR) mRNA in adipose tissues of obese than in those of lean individuals, suggesting that idiopathic obesity involves GH resistance due to decreased GHR availability. To understand the mechanism(s) behind this downregulation, we performed an in silico analysis of the three most relevant GHR gene promoters, which revealed putative response elements (REs) for a number of obesity adipose-associated factors, including tumor necrosis factor-alpha (TNFα), hypoxia-inducible factor-1-alpha (HIF-1α) and glucocorticoids. We then characterized the dose-dependent effects of these factors on GHR expression in HEK293 cells and in mature human SGBS (Simpson-Golabi-Behmel syndrome) adipocytes using quantitative reverse transcriptase-PCR and assessed the function of their putative REs by luciferase-reporter assays, site-directed mutagenesis and chromatin immunoprecipitation (ChIP) assays., Results: TNFα treatments significantly reduced GHR mRNA levels and GHR promoter activities at doses ≥ 10 ng ml(-1) in both cell lines. Transient overexpression of HIF-1α or exposure to the hypoxia mimetic CoCl(2) significantly increased GHR mRNA levels and promoter activities. Dexamethasone had biphasic effects: there was a significant increase in GHR mRNA levels at 10(-10) M and in promoter activities at 10(-10) and 10(-8) M, whereas a significant decrease in both mRNA levels and promoter activities occurred at 10(-6) M. Site-directed mutagenesis of the putative nuclear factor-κB, HIF-1α and glucocorticoid REs resulted in the loss of these effects, whereas ChIP analysis confirmed specific transcription factor-promoter interactions., Conclusions: Our results suggest that the increased activity of TNFα, HIF-1α and glucocorticoids in obese adipose tissues could alter GHR gene transcription through specific REs and that TNFα may be involved in the development of GH resistance.
- Published
- 2011
- Full Text
- View/download PDF
30. Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidism.
- Author
-
Puzhko S, Goodyer CG, Kerachian MA, Canaff L, Misra M, Jüppner H, Bastepe M, and Hendy GN
- Subjects
- Blotting, Western, Cell Line, Cyclic AMP metabolism, GTP-Binding Proteins chemistry, Humans, GTP-Binding Proteins metabolism, Parathyroid Hormone metabolism, Pseudohypoparathyroidism metabolism, Signal Transduction
- Abstract
Pseudohypoparathyroid patients have resistance predominantly to parathyroid hormone (PTH), and here we have examined the ability of an alternative Gαs-related protein to inhibit Gαs activity in a hormone-selective manner. We tested whether the GNAS exon A/B-derived NH(2)-terminally truncated (Tr) αs protein alters stimulation of adenylate cyclase by the PTH receptor (PTHR1), the thyroid-stimulating hormone (TSH) receptor (TSHR), the β(2)-adrenergic receptor (β(2)AR), or the AVP receptor (V2R). HEK293 cells cotransfected with receptor and full-length (FL) Gαs ± Tr αs protein expression vectors were stimulated with agonists (PTH [10(-7) to 10(-9) M], TSH [1 to 100 mU], isoproterenol [10(-6) to 10(-8) M], or AVP [10(-6) to 10(-8) M]). Following PTH stimulation, HEK293 cells cotransfected with PTHR1 + FL Gαs + Tr αs had a significantly lower cAMP response than those transfected with only PTHR1 + FL Gαs. Tr αs also exerted an inhibitory effect on the cAMP levels stimulated by TSH via the TSHR but had little or no effect on isoproterenol or AVP acting via β(2)AR or V2R, respectively. These differences mimic the spectrum of hormone resistance in pseudohypoparathyroidism type 1a (PHP-1a) and type 1b (PHP-1b) patients. In opossum kidney (OK) cells, endogenously expressing the PTHR1 and β(2)AR, the exogenous expression of Tr αs at a level similar to endogenous FL Gαs resulted in blunting of the cAMP response to PTH, whereas that to isoproterenol was unaltered. A pseudopseudohypoparathyroid patient with Albright hereditary osteodystrophy harbored a de novo paternally inherited M1I Gαs mutation. Similar maternally inherited mutations at the initiation codon have been identified previously in PHP-1a patients. The M1I αs mutant (lacking the first 59 amino acids of Gαs) blunted the increase in cAMP levels stimulated via the PTHR1 in both HEK293 and OK cells similar to the Tr αs protein. Thus NH(2)-terminally truncated forms of Gαs may contribute to the pathogenesis of pseudohypoparathyroidism by inhibiting the activity of Gαs itself in a GPCR selective manner., (Copyright © 2011 American Society for Bone and Mineral Research.)
- Published
- 2011
- Full Text
- View/download PDF
31. p75(NTR) induces apoptosis in medulloblastoma cells.
- Author
-
Küchler J, Hartmann W, Waha A, Koch A, Endl E, Wurst P, Kindler D, Mikeska T, Waha A, Goodyer CG, Büttner R, Schilling K, and Pietsch T
- Subjects
- Animals, Blotting, Western, Cerebellar Neoplasms metabolism, CpG Islands, DNA Methylation, DNA, Neoplasm genetics, Female, Flow Cytometry, Hedgehog Proteins genetics, Hedgehog Proteins metabolism, Humans, Immunoenzyme Techniques, Medulloblastoma metabolism, Mice, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Knockout, Multicenter Studies as Topic, Neurons, Polymerase Chain Reaction, Polymorphism, Single-Stranded Conformational, RNA, Messenger genetics, RNA, Neoplasm genetics, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Tumor Cells, Cultured, Apoptosis, Cerebellar Neoplasms pathology, Medulloblastoma pathology, Receptor, Nerve Growth Factor physiology
- Abstract
The classic medulloblastoma (CMB) and the desmoplastic medulloblastoma (DMB) subtypes represent the major medulloblastoma variants. In contrast to CMB, DMB display high levels of the low-affinity nerve growth factor receptor p75(NTR) . Given the reports of a better clinical course of DMB, we hypothesized that p75(NTR) might act as a tumor suppressor in medulloblastomas. In a large set of medulloblastomas, p75(NTR) was screened for mutations, and its mRNA expression and the DNA methylation status of its 5'-region were assessed. p75(NTR) immunostainings were performed in wild-type murine cerebella and medulloblastomas arising in patched heterozygous mice, and murine cerebellar granule cell precursors (GCP) were analyzed in vitro. Medulloblastoma cells engineered to express p75(NTR) were characterized flow cytometrically and morphologically. One CMB displayed a mutation of the p75(NTR) coding sequence. p75(NTR) mRNA levels clearly delineated DMB and CMB; however, CpG island hypermethylation was excluded as the cause of low p75(NTR) expression in CMB. Sonic Hedgehog-treated GCP showed elevated p75(NTR) expression, and strong expression of p75(NTR) was detected in the external granule cell layer of wild-type mice and in murine ptc(±) medulloblastomas. CMB cells overexpressing p75(NTR) displayed a significant increase in apoptosis. In summary, our data link activated Hedgehog signaling in DMB with p75(NTR) expression and characterize p75(NTR) as a biologically relevant inductor of apoptosis in MB., (Copyright © 2010 UICC.)
- Published
- 2011
- Full Text
- View/download PDF
32. Human growth hormone receptor gene expression is regulated by Gfi-1/1b and GAGA cis-elements.
- Author
-
Kenth G, Puzhko S, and Goodyer CG
- Subjects
- Cell Line, Chromatin Immunoprecipitation, DNA-Binding Proteins biosynthesis, Drosophila Proteins biosynthesis, Drosophila Proteins metabolism, Electrophoretic Mobility Shift Assay, Gene Expression Regulation, Humans, Liver cytology, Liver embryology, Receptors, Somatotropin metabolism, Recombinant Proteins biosynthesis, Recombinant Proteins metabolism, STAT5 Transcription Factor metabolism, Transcription Factors biosynthesis, Transcription, Genetic, DNA-Binding Proteins metabolism, Proto-Oncogene Proteins metabolism, Receptors, Somatotropin genetics, Repressor Proteins metabolism, Response Elements, Transcription Factors metabolism
- Abstract
Human growth hormone receptor (hGHR) gene regulation is complex: mRNAs are transcribed from multiple variant (V) 5'UTR exons, several ubiquitously while others only in the postnatal hepatocyte. The liver-specific V1 exon promoter contains Gfi-1/1b repressor sites adjacent to a GAGA box, a GH response element (GHRE) in several mammalian genes. GAGA boxes are also present in the ubiquitously expressing V3 exon promoter. Heterologous sites in bovine, ovine and murine GHR genes suggest conserved roles. GAGA factor stimulated V1 and V3 promoters while Gfi-1/1b repressed basal and GAF-stimulated V1 transcription. HGH treatment of HepG2 cells resulted in a new complex forming with V3 GAGA elements, suggesting a functional GHRE. Data suggest liver-specific V1 transcription is regulated by inhibitory Gfi-1/1b and stimulatory GAGA cis-elements and Gfi-1/1b may control the lack of V1 expression in fetal liver, hepatic tumours and non-hepatic tissues. In addition, hGH may regulate hGHR expression through V3 GAGA boxes., (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
33. Integrin {alpha}3, but not {beta}1, regulates islet cell survival and function via PI3K/Akt signaling pathways.
- Author
-
Krishnamurthy M, Li J, Fellows GF, Rosenberg L, Goodyer CG, and Wang R
- Subjects
- Aged, Androstadienes pharmacology, Animals, Antibodies pharmacology, Blotting, Western, Butadienes pharmacology, Cell Line, Fluorescent Antibody Technique, Humans, In Vitro Techniques, Integrin alpha3 genetics, Integrin alpha3 immunology, Integrin beta1 genetics, Integrin beta1 immunology, Islets of Langerhans cytology, Middle Aged, Nitriles pharmacology, Phosphoinositide-3 Kinase Inhibitors, Rats, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction genetics, Wortmannin, Integrin alpha3 metabolism, Integrin beta1 metabolism, Islets of Langerhans drug effects, Islets of Langerhans metabolism, Phosphatidylinositol 3-Kinase metabolism, Proto-Oncogene Proteins c-akt metabolism, Signal Transduction drug effects
- Abstract
β1-integrin is a well-established regulator of β-cell activities; however, the role of its associated α-subunits is relatively unknown. Previously, we have shown that human fetal islet and INS-1 cells highly express α3β1-integrin and that collagens I and IV significantly enhance their survival and function; in addition, blocking β1 function in the fetal islet cells decreased adhesion on collagen I and increased apoptosis. The present study investigates the effect of blocking α3. Using α3 blocking antibody or small interfering RNA, the effects of α3-integrin blockade were examined in isolated human fetal or adult islet cells or INS-1 cells, cultured on collagens I or IV. In parallel, β1 blockade was analyzed in INS-1 cells. Perturbing α3 function in human islet or INS-1 cells resulted in significant decreases in cell function (adhesion, spreading, proliferation and Pdx1 and insulin expression/secretion), primarily on collagen IV. A significant decrease in focal adhesion kinase and ERK1/2 phosphorylation and increased caspase3 cleavage were observed on both collagens. These effects were similar to changes after β1 blockade. Interestingly, only α3 blockade reduced expression of phospho-Akt and members of its downstream signaling cascades (glycogen synthase kinase β and X-linked inhibitor of apoptosis), demonstrating a specific effect of α3 on the phosphatidylinositol 3-kinase/Akt pathway. These results suggest that α3- as well as β1-integrin-extracellular matrix interactions are critical for modulating β-cell survival and function through specialized signaling cascades and enhance our understanding of how to improve islet microenvironments for cell-based treatments of diabetes.
- Published
- 2011
- Full Text
- View/download PDF
34. GC-MS analysis of bisphenol A in human placental and fetal liver samples.
- Author
-
Zhang J, Cooke GM, Curran IH, Goodyer CG, and Cao XL
- Subjects
- Animals, Benzhydryl Compounds, Cattle, Female, Humans, Kidney chemistry, Meat analysis, Myocardium chemistry, Pregnancy, Reproducibility of Results, Sensitivity and Specificity, Swine, Fetus chemistry, Gas Chromatography-Mass Spectrometry methods, Liver chemistry, Phenols analysis, Placenta chemistry
- Abstract
A method based on extraction with acetonitrile, followed by solid-phase extraction, derivatization with acetic anhydride, and isotope dilution gas chromatography-mass spectrometry (GC-MS) analysis was applied to determine levels of free and conjugated BPA in human tissues. β-Glucuronidase was used to de-conjugate the glucuronized BPA in the samples. The method was validated using various animal organ meat samples including pork liver and kidney, beef and calf liver, chicken liver and heart; recoveries were from 85% to 112% at two spiking levels. The average method limit of quantification (LOQ) was estimated at 0.77 ng/g for placenta samples and 1.2 ng/g for fetal liver samples based on 10 times the signal to noise ratio. BPA was detected in all animal tissue samples, with concentrations ranging from 1.8 ng/g in beef and calf livers to 17.1 ng/g in pork kidney. The method was used successfully to determine both free and conjugated BPA levels in human placental and fetal liver tissue samples. BPA was detected in 86% of the placental samples; concentrations of free BPA in the positive samples ranged from 0.60 ng/g to as high as 64 ng/g with an average of 9.5 ng/g and a median of 3.0 ng/g, and conjugated BPA was as high as 7.8 ng/g. BPA was also detected in most of the fetal liver samples (57%); concentrations of free BPA in the positive samples ranged from 1.3 to 27 ng/g with an average of 8.5 ng/g and a median of 3.2 ng/g. Conjugated BPA was also detected in most of the liver samples analysed for total BPA, ranging from 0.64 to 20 ng/g with an average of 3.9 ng/g and a median of 1.5 ng/g. This study, while primarily designed as a method validation, has demonstrated that BPA can be detected in human fetal liver samples as early as the third month of fetal life. Further work will be conducted to validate these preliminary findings., (Crown Copyright © 2010. Published by Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
35. Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures.
- Author
-
Sivananthan SN, Lee AW, Goodyer CG, and LeBlanc AC
- Subjects
- Alzheimer Disease metabolism, Amino Acid Chloromethyl Ketones pharmacology, Amyloid beta-Peptides metabolism, Amyloid beta-Protein Precursor genetics, Caspase Inhibitors, Cell Differentiation, Cells, Cultured, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Humans, Luminescent Proteins genetics, Luminescent Proteins metabolism, Neurogenesis, Neurons cytology, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Ubiquitin genetics, Ubiquitin metabolism, tau Proteins genetics, tau Proteins metabolism, Red Fluorescent Protein, Amyloid beta-Protein Precursor metabolism, Caspase 6 metabolism, Nerve Degeneration, Neurons metabolism
- Abstract
Although familial Alzheimer disease (AD)-associated autosomal dominant mutants have been extensively studied, little is known about the underlying molecular mechanisms of neurodegeneration induced by these mutants in AD. Wild-type, Swedish or London amyloid precursor protein (APP) transfection in primary human neurons induced neuritic beading, in which several co-expressed proteins, such as enhanced green fluorescent protein, red fluorescent protein (RFP)-tau and RFP-ubiquitin, accumulated. APP-induced neuritic beading was dependent on caspase-6 (Casp6), because it was inhibited with 5 μM z-VEID-fmk or with dominant-negative Casp6. Neuritic beading was independent from APP-mediated amyloid β-peptide (Aβ) production, because the APPM596V (APP(MV)) mutant, which cannot generate Aβ, still induced Casp6-dependent neuritic beading. However, the beaded neurons underwent Casp6- and Aβ-dependent cell death. These results indicate that overexpression of wild-type or mutant APP causes Casp6-dependent but Aβ-independent neuritic degeneration in human neurons. Because Casp6 is activated early in AD and is involved in axonal degeneration, these results suggest that the inhibition of Casp6 may represent an efficient early intervention against familial forms of AD. Furthermore, these results indicate that removing Aβ without inhibiting Casp6 may have little effect in preventing the progressive dementia associated with sporadic or familial AD.
- Published
- 2010
- Full Text
- View/download PDF
36. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas.
- Author
-
Al-Masri M, Krishnamurthy M, Li J, Fellows GF, Dong HH, Goodyer CG, and Wang R
- Subjects
- Animals, Cell Differentiation, Female, Forkhead Box Protein O1, Forkhead Transcription Factors drug effects, Forkhead Transcription Factors physiology, Gene Expression Regulation, Developmental, Glucagon genetics, Humans, Insulin genetics, Insulin pharmacology, Insulin-Secreting Cells cytology, Insulin-Secreting Cells drug effects, Islets of Langerhans embryology, Mice, Pregnancy, RNA, Small Interfering genetics, Reverse Transcriptase Polymerase Chain Reaction, Transcription Factors metabolism, Transfection, Fetal Development physiology, Forkhead Transcription Factors genetics, Insulin-Secreting Cells physiology, Pancreas embryology
- Abstract
Aims/hypothesis: Recent studies have demonstrated that in adult murine beta cells the forkhead box O1 (FOXO1) transcription factor regulates proliferation and stress resistance. However, the role of FOXO1 during pancreatic development remains largely unknown. The present study aimed to characterise the expression of the FOXO1 transcription factor in the early to mid-gestation human fetal pancreas and to understand its role in islet cell development., Methods: Human (8-21 week fetal age) pancreases were examined using immunohistological, quantitative RT-PCR and western blotting. Isolated human (18-21 week) fetal islet epithelial cell clusters were treated with insulin or glucose, or transfected with FOXO1 small interfering RNA (siRNA)., Results: Nuclear and cytoplasmic FOXO1 were widely produced during human fetal endocrine pancreatic development, co-localising in cells with the transcription factors pancreatic and duodenal homeobox 1 (PDX-1) and neurogenin 3 (NGN3) as well as cytokeratin 19 (CK19), insulin and glucagon. Treatment with exogenous insulin (50 nmol/l) induced the nuclear exclusion of FOXO1 in both cytokeratin 19 (CK19)(+) (p < 0.01) and insulin(+) cells (p < 0.05) in parallel with increased phospho-Akt (p < 0.05) production. siRNA knockdown of FOXO1 significantly increased the number of NGN3(+) (p < 0.01) and NK6 homeobox 1 (NKX6-1)(+) (p < 0.05) cells in parallel with increases in insulin gene expression (p < 0.03) and C-peptide(+) cells (p < 0.05) and reduced levels of hairy and enhancer of split 1 (HES1) (p < 0.01)., Conclusions/interpretation: Our results indicate that FOXO1 may negatively regulate beta cell differentiation in the human fetal pancreas by controlling critical transcription factors, including NGN3 and NKX6-1. These data suggest that the manipulation of FOXO1 levels may be a useful tool for improving cell-based strategies for the treatment of diabetes.
- Published
- 2010
- Full Text
- View/download PDF
37. Conserved usage of alternative 5' untranslated exons of the GATA4 gene.
- Author
-
Mazaud Guittot S, Bouchard MF, Robert-Grenon JP, Robert C, Goodyer CG, Silversides DW, and Viger RS
- Subjects
- Aging genetics, Alternative Splicing genetics, Animals, Base Sequence, Fetus metabolism, Gene Expression Profiling, Gene Expression Regulation, Developmental, Humans, Mice, Molecular Sequence Data, Nucleic Acid Conformation, Organ Specificity genetics, Polyribosomes metabolism, Protein Biosynthesis, RNA, Messenger chemistry, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, 5' Untranslated Regions genetics, Exons genetics, GATA4 Transcription Factor genetics
- Abstract
Background: GATA4 is an essential transcription factor required for the development and function of multiple organs. Despite this important role, our knowledge of how the GATA4 gene is regulated remains limited. To better understand this regulation, we characterized the 5' region of the mouse, rat, and human GATA4 genes., Methodology/principal Findings: Using 5' RACE, we identified novel transcription start sites in all three species. GATA4 is expressed as multiple transcripts with varying 5' ends encoded by alternative untranslated first exons. Two of these non-coding first exons are conserved between species: exon 1a located 3.5 kb upstream of the GATA4 ATG site in exon 2, and a second first exon (exon 1b) located 28 kb further upstream. Expression of both mRNA variants was found in all GATA4-expressing organs but with a preference for the exon 1a-containing transcript. The exception was the testis where exon 1a- and 1b-containing transcripts were similarly expressed. In some tissues such as the intestine, alternative transcript expression appears to be regionally regulated. Polysome analysis suggests that both mRNA variants contribute to GATA4 protein synthesis., Conclusions/significance: Taken together, our results indicate that the GATA4 gene closely resembles the other GATA family members in terms of gene structure where alternative first exon usage appears to be an important mechanism for regulating its tissue- and cell-specific expression.
- Published
- 2009
- Full Text
- View/download PDF
38. The emerging role of SOX transcription factors in pancreatic endocrine cell development and function.
- Author
-
McDonald E, Krishnamurthy M, Goodyer CG, and Wang R
- Subjects
- Animals, Gene Expression Regulation, Developmental, Humans, SOX Transcription Factors genetics, Endocrine Glands cytology, Endocrine Glands embryology, Pancreas cytology, Pancreas embryology, SOX Transcription Factors metabolism
- Abstract
The transition of pancreatic progenitor cells to mature beta cells is regulated by the interaction of several transcription factors, including members of the sex-determining region on Y box (SOX) family of transcription factors. The SOX proteins are widely involved in cell fate determination and the development of several tissues, including bone, heart, gonads, lymphocytes, and glial cells as well as the pancreas. In this review, we will present recent findings that illustrate the critical role of SOX transcription factors in maintaining pancreatic progenitor cell pools and in controlling pancreatic islet morphogenesis and islet function. Interrelationships between the SOX family and other pancreatic transcription factors specific to endocrine lineages will also be discussed in light of islet cell-based therapies for the treatment of diabetes.
- Published
- 2009
- Full Text
- View/download PDF
39. beta1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival.
- Author
-
Saleem S, Li J, Yee SP, Fellows GF, Goodyer CG, and Wang R
- Subjects
- Cell Adhesion physiology, Cell Differentiation physiology, Cell Survival physiology, Cells, Cultured, Epithelial Cells cytology, Fetal Development physiology, Gene Knockdown Techniques, Humans, Integrin beta1 genetics, Islets of Langerhans cytology, Focal Adhesion Kinase 1 physiology, Integrin beta1 physiology, Islets of Langerhans embryology, MAP Kinase Signaling System physiology
- Abstract
beta1 integrin and collagen matrix interactions regulate the survival of cells by associating with focal adhesion kinase (FAK) and initiating MAPK/ERK signalling, but little is known about these signalling pathways during human fetal islet ontogeny. The purpose of this study was to investigate whether beta1 integrin/FAK activation of the MAPK/ERK pathway regulates human fetal islet cell expression of endocrine cell markers and survival. Isolated human (18-21 weeks fetal age) islet-epithelial cell clusters, cultured on collagen I, were examined using beta1 integrin blocking antibody, beta1 integrin siRNA and FAK expression vector. Perturbing beta1 integrin function in the human fetal islet-epithelial cell clusters resulted in a marked decrease in cell adhesion, in parallel with a reduction in the number of cells expressing PDX-1, insulin and glucagon (p < 0.05). beta1 integrin blockade disorganized focal adhesion contacts in the PDX-1(+) cells and decreased activation of FAK and ERK1/2 signalling in parallel with an increase in expression of cleaved caspases 9 and 3 (p < 0.01). Similar results were obtained following an siRNA knock-down of beta1 integrin expression. In contrast, over-expression of FAK not only increased phospho-ERK and the expression of PDX-1, insulin and glucagon (p < 0.05) but also abrogated the decreases in phospho-ERK and PDX-1 by beta1 integrin blockade. This study demonstrates that activation of the FAK/ERK signalling cascade by beta1 integrin is involved in the differentiation and survival of human fetal pancreatic islet cells., (2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.)
- Published
- 2009
- Full Text
- View/download PDF
40. Loss of anti-Bax function in Gerstmann-Sträussler-Scheinker syndrome-associated prion protein mutants.
- Author
-
Jodoin J, Misiewicz M, Makhijani P, Giannopoulos PN, Hammond J, Goodyer CG, and LeBlanc AC
- Subjects
- Caspases metabolism, Cell Line, Tumor, DNA Fragmentation, Enzyme Activation, Humans, Gerstmann-Straussler-Scheinker Disease genetics, Mutation, Prions genetics, bcl-2-Associated X Protein genetics
- Abstract
Previously, we have shown the loss of anti-Bax function in Creutzfeldt Jakob disease (CJD)-associated prion protein (PrP) mutants that are unable to generate cytosolic PrP (CyPrP). To determine if the anti-Bax function of PrP modulates the manifestation of prion diseases, we further investigated the anti-Bax function of eight familial Gerstmann-Sträussler-Scheinker Syndrome (GSS)-associated PrP mutants. These PrP mutants contained their respective methionine ((M)) or valine ((V)) at codon 129. All of the mutants lost their ability to prevent Bax-mediated chromatin condensation or DNA fragmentation in primary human neurons. In the breast carcinoma MCF-7 cells, the F198S(V), D202N(V), P102L(V) and Q217R(V) retained, whereas the P102L(M), P105L(V), Y145stop(M) and Q212P(M) PrP mutants lost their ability to inhibit Bax-mediated condensed chromatin. The inhibition of Bax-mediated condensed chromatin depended on the ability of the mutants to generate cytosolic PrP. However, except for the P102L(V), none of the mutants significantly inhibited Bax-mediated caspase activation. These results show that the cytosolic PrP generated from the GSS mutants is not as efficient as wild type PrP in inhibiting Bax-mediated cell death. Furthermore, these results indicate that the anti-Bax function is also disrupted in GSS-associated PrP mutants and is not associated with the difference between CJD and GSS.
- Published
- 2009
- Full Text
- View/download PDF
41. Persistent organic pollutant residues in human fetal liver and placenta from Greater Montreal, Quebec: a longitudinal study from 1998 through 2006.
- Author
-
Doucet J, Tague B, Arnold DL, Cooke GM, Hayward S, and Goodyer CG
- Subjects
- Aborted Fetus chemistry, Female, Humans, Liver embryology, Longitudinal Studies, Quebec, Environmental Pollutants analysis, Halogenated Diphenyl Ethers analysis, Hydrocarbons, Chlorinated analysis, Liver chemistry, Placenta chemistry, Polychlorinated Biphenyls analysis
- Abstract
Background: There is general concern that persistent organic pollutants (POPs) found in the environment, wildlife, food, water, house dust, human tissues, and fluids may alter normal human physiologic activities (e.g., fetal development, immune and endocrine systems). Although the levels of some POPs [polychlorinated biphenyls (PCBs) and organochlorine pesticides (OCs)] in these matrices have decreased after their ban, others [polybrominated diphenyl ethers (PBDEs)] have increased in recent years., Objective: To determine the longitudinal trend of specific POPs in human fetal tissues for risk assessment purposes., Methods: We analyzed early to mid-gestation fetal liver (n = 52) and placental (n = 60) tissues, obtained after elective abortions during 1998-2006, for selected PBDEs, PCBs, and OCs using gas chromatography-mass spectroscopy., Results: Total PBDEs in fetal liver increased over time (mean +/- SE: 1998, 284.4 +/- 229.8 ng/g lipid; 2006, 1,607.7 +/- 605.9; p < 0.03), whereas placental levels were generally lower, with no clear trend. Low levels of PCBs and OCs varied yearly, with no evident trend. The major analytes in 1998 were OCs (liver, 49%; placenta, 71%), whereas the major analytes in 2006 were PBDEs (liver, 89%; placenta, 98%). The 1998-2006 tissue PBDE congener profile is similar to that of DE-71, a commercial primarily pentabrominated diphenyl ether mixture manufactured in North America., Conclusions: Although commercial production of penta- and octa-brominated diphenyl ethers in North America was halted in 2004, their concentrations in fetal liver and placenta are now greater than the tissue burdens for the analyzed OCs and PCBs. Our findings also demonstrate that PBDEs accumulate within the fetal compartment at a very early stage in gestation.
- Published
- 2009
- Full Text
- View/download PDF
42. Structure and activity of the human growth hormone receptor (hGHR) gene V2 promoter.
- Author
-
Wei Y, Puzhko S, Wabitsch M, and Goodyer CG
- Subjects
- Adipocytes metabolism, Animals, Base Sequence, COS Cells, Cells, Cultured, Chlorocebus aethiops, Chromosome Mapping, DNA analysis, DNA chemistry, Gene Deletion, Humans, Membrane Proteins chemistry, Membrane Proteins metabolism, Membrane Proteins physiology, Molecular Sequence Data, Promoter Regions, Genetic genetics, Structure-Activity Relationship, Transcription, Genetic physiology, Membrane Proteins genetics, Nucleic Acid Conformation, Promoter Regions, Genetic physiology
- Abstract
Human GH (hGH) has important effects on growth as well as carbohydrate, fat, and protein metabolism. These actions require the presence of normal levels of a functional hGH receptor (hGHR) on the surface of target cells. hGHR gene expression is characterized by the use of several 5'-noncoding exons and alternative splicing, resulting in the generation of multiple mRNA isoforms. The hGHR V2 transcript is predominant in most tissues, including human fat. However, factors regulating its ubiquitous expression have remained unidentified. The present study was aimed at characterizing the mechanisms regulating hGHR V2 transcription. Two major V2 transcriptional start sites were identified by primer extension assays. The V2 proximal promoter is TATA-less, with several characteristics of a housekeeping gene promoter. Transient transfection analyses of 2.6 kb of the 5'-flanking region of V2 confirmed its promoter activity in multiple primate cell lines. Similar promoter activity patterns were observed in human SGBS preadipocytes and mature adipocytes but with much higher V2 promoter activity in mature adipocytes, suggesting that changes in the availability of specific factors during adipocyte differentiation play a role in V2 promoter regulation. Serial deletion and mutation analyses revealed that transcription of hGHR V2 in different cell types, including adipocytes, is determined by a core promoter and distinct inhibitory and activation domains in the 5'-promoter region as well as within the V2 exon. Our data suggest that V2 transcription is the result of a complex interplay involving multiple factors, to ensure appropriate expression of hGHR in different hGH target cells.
- Published
- 2009
- Full Text
- View/download PDF
43. Transcriptional regulation of the human growth hormone receptor (hGHR) gene V2 promoter by transcriptional activators and repressor.
- Author
-
Wei Y, Puzhko S, Wabitsch M, and Goodyer CG
- Subjects
- Animals, Base Sequence, Basic Helix-Loop-Helix Transcription Factors metabolism, Basic Helix-Loop-Helix Transcription Factors physiology, Binding Sites, COS Cells, Cells, Cultured, Chlorocebus aethiops, Homeodomain Proteins metabolism, Homeodomain Proteins physiology, Humans, Models, Biological, Molecular Sequence Data, Protein Binding, Proto-Oncogene Protein c-ets-1 metabolism, Proto-Oncogene Protein c-ets-1 physiology, Sequence Homology, Nucleic Acid, Transcription Factor CHOP metabolism, Transcription Factor CHOP physiology, Transcription Factor HES-1, Gene Expression Regulation, Membrane Proteins genetics, Promoter Regions, Genetic physiology, Repressor Proteins physiology, Trans-Activators physiology
- Abstract
The V2 transcript is the major ubiquitously expressed human GH receptor (hGHR) mRNA in all tissues examined to date. In a previous investigation, we defined the V2 promoter as TATA-less and exhibiting many characteristics of a housekeeping gene promoter. We also demonstrated that its basal activity is determined by several different cis-regulatory regions within both the promoter and the V2 exon. In the present study, we used luciferase-reporter, site-directed mutagenesis, gel shift, chromatin immunoprecipitation, and quantitative RT-PCR assays to investigate the ability of certain transcription factors to regulate hGHR V2 transcription through these regions in mammalian cells, including human adipocytes. Ets1 was found to transactivate the V2 proximal promoter through specific Ets sites. Two CCAAT/enhancer-binding protein (C/EBP) family members [C/EBP-homologous protein (CHOP) and C/EBPbeta] enhanced V2 transcription via different pathways: indirectly, by association with a V2 exon region (CHOP), and directly, using a V2 proximal promoter noncanonical binding site (C/EBPbeta). The Notch signaling mediator, Hes1, potently suppressed V2 promoter activity through interaction with two Hes sites within the V2 exon. We propose that these transcriptional factors regulate hGHR V2 expression by acting as downstream nuclear effectors, linking specific signaling cascades (e.g. MAPK and Notch) triggered by different growth factor-, development-, and nutrition- as well as stress-related stimuli. Our data also suggest that these factors are likely to be important in the differentiation-induced increase in V2 mRNA expression in adipocytes, with Ets1 and CHOP functioning at the preadipocyte stage to prepare the cells for differentiation and increasing C/EBPs and decreasing Hes1 levels contributing during adipocyte maturation.
- Published
- 2009
- Full Text
- View/download PDF
44. Cytosolic prion protein is the predominant anti-Bax prion protein form: exclusion of transmembrane and secreted prion protein forms in the anti-Bax function.
- Author
-
Lin DT, Jodoin J, Baril M, Goodyer CG, and Leblanc AC
- Subjects
- Animals, Apoptosis drug effects, Cell Line, Humans, Mice, Mutation genetics, Neurons drug effects, Neurons metabolism, Prions genetics, Protein Binding, Cell Membrane metabolism, Cytosol metabolism, Prions metabolism, bcl-2-Associated X Protein antagonists & inhibitors, bcl-2-Associated X Protein metabolism
- Abstract
Prion protein (PrP) prevents Bax-mediated cell death by inhibiting the initial Bax conformational change that converts cytosolic Bax into a pro-apoptotic protein. PrP is mostly a glycophosphatidylinositol-anchored cell surface protein but it is also retrotranslocated into cytosolic PrP (CyPrP) or can become a type 1 or type 2 transmembrane protein. To determine the form and subcellular location of the PrP that has anti-Bax function, we co-expressed various Syrian hamster PrP (SHaPrP) mutants that favour specific PrP topologies and subcellular localization with N-terminally green fluorescent protein tagged pro-apoptotic Bax (EGFP-Bax) in MCF-7 cells and primary human neurons. Mutants that generate both CyPrP and secreted PrP ((Sec)PrP) or only CyPrP have anti-Bax activity. Mutants that produce (Ctm)PrP or (Ntm)PrP lose the anti-Bax activity, despite their ability to also make (Sec)PrP. Transmembrane-generating mutants do not produce CyPrP and both normal and cognate mutant forms of CyPrP rescue against the loss of anti-Bax activity. (Sec)PrP-generating constructs also produce non-membrane attached (Sec)PrP. However, this form of PrP has minimal anti-Bax activity. We conclude that CyPrP is the predominant form of PrP with anti-Bax function. These results imply that the retrotranslocation of PrP encompasses a survival function and is not merely a pathway for the proteasomal degradation of misfolded protein.
- Published
- 2008
- Full Text
- View/download PDF
45. Developmental changes in the human GH receptor and its signal transduction pathways.
- Author
-
Kenth G, Mergelas JA, and Goodyer CG
- Subjects
- Animals, Cell Line, Hepatocytes chemistry, Humans, Janus Kinase 2 analysis, Janus Kinase 2 physiology, Liver chemistry, Membrane Proteins genetics, Membrane Proteins physiology, RNA, Messenger analysis, STAT Transcription Factors analysis, STAT Transcription Factors physiology, Suppressor of Cytokine Signaling Proteins analysis, Suppressor of Cytokine Signaling Proteins physiology, Fetus chemistry, Membrane Proteins analysis, Signal Transduction
- Abstract
We previously reported the presence of functional human GH receptors (hGHRs) in the human fetal hepatocyte (FH) as early as the first trimester. Interestingly, fetal serum levels of hGH are in the acromegalic range, yet certain hGH-dependent factors are expressed at very low levels (IGF-I, IGF-binding protein-3), suggesting that fetal liver has limited responsiveness to hGH. To determine whether this is due to the fetal tissue levels of hGHR or factors in the hGH/hGHR axis that might influence hGHR function, we compared hGHR isoforms and downstream signaling proteins in FH versus human adult liver (HAL). Immunoprecipitation/immunoblotting (IB) analyses found similar precursor and mature hGHR forms while RT-PCR assays of truncated (T) hGHR(1-279), dominant negative for the full-length (FL) receptor, showed similar T/FL mRNA ratios in FH and HAL. IB demonstrated that Janus kinase (JAK) 2, signal transducers and activators of transcription (STAT(1, 3, 5A/B)), and suppressors of cytokine signaling (SOCS(1, 2, 3, cytokine-inducible SH2-containing protein (CIS))) proteins were detectable in all FH and HAL tested (12 weeks of fetal age to 60 years); the levels were similar (STAT5B) or lower (JAK2/STAT1/STAT3/STAT5A: 38-53%, SOCS/CIS: 58-76%) in FH compared with HAL. Our studies to date demonstrate that, during hepatocyte development, hGHR levels are lower in the fetal cells but the hGHR isoforms, including the relative amount of truncated versus FL, remain unchanged. The JAK2/STAT/SOCS signaling molecules are present in the FH as early as the first trimester. However, they are generally at <50% level in postnatal liver. These data suggest that low expression of both hGHR and major hGHR signaling components may explain the limited responsiveness of the fetal cells to the high circulating levels of hGH.
- Published
- 2008
- Full Text
- View/download PDF
46. Transcription factor expression in the developing human fetal endocrine pancreas.
- Author
-
Lyttle BM, Li J, Krishnamurthy M, Fellows F, Wheeler MB, Goodyer CG, and Wang R
- Subjects
- Basic Helix-Loop-Helix Transcription Factors genetics, Biomarkers, Down-Regulation genetics, Gestational Age, Hepatocyte Nuclear Factor 1-alpha genetics, Hepatocyte Nuclear Factor 3-beta genetics, Hepatocyte Nuclear Factor 6 genetics, Homeobox Protein Nkx-2.2, Homeodomain Proteins genetics, Humans, Nerve Tissue Proteins genetics, Nuclear Proteins, Paired Box Transcription Factors genetics, Snail Family Transcription Factors, Trans-Activators genetics, Up-Regulation genetics, Zebrafish Proteins, Gene Expression Profiling, Gene Expression Regulation, Developmental, Pancreas embryology, Pancreas physiology, Transcription Factors genetics
- Abstract
Aims/hypothesis: Morphological changes that occur during pancreatic endocrine cell differentiation have been shown in rodent systems to be dependent on sequential alterations in transcription factor expression. However, similar data for humans have been limited. The aim of the present study was to provide a connection between pancreatic morphology, transcription factor gene expression and protein localisation during human fetal development., Methods: Human fetal pancreases were examined at early (8-12 weeks of fetal age), middle (14-16 weeks) and late (19-21 weeks) stages, using immunohistological, microarray and qRT-PCR analyses., Results: We observed a significant decrease in pancreatic duodenal homeobox 1 (PDX-1)(+)/cytokeratin 19(+) cells (p < 0.001), with a simultaneous increase in PDX-1(+)/insulin(+) cells from 8 to 21 weeks (p < 0.05). Increased PDX-1/insulin co-localisation within islet clusters was noted, while no co-expression of PDX-1 with glucagon was found, suggesting that loss of PDX-1 is essential for alpha cell formation. Given that neurogenin 3 (NGN3) expression is critical for establishing the endocrine cell programme in the rodent pancreas, we examined its expression pattern and co-localisation in PDX-1(+), insulin(+) and glucagon(+) cells. Co-localisation of NGN3 with PDX-1, insulin and glucagon was noted during early development, with significant decreases in middle and late stages (p < 0.001). Our microarray and co-localisation analyses of transcription factors linked to NGN3 demonstrated that ISL1 transcription factor (ISL1), neurogenic differentiation 1 (NEUROD1), NK2 related transcription factor related, locus 2 (NKX2-2) and paired box gene 6 (PAX6) were upregulated during development and present in all four endocrine cell types, while NK6 related transcription factor related, locus 1 (NKX6-1) was expressed exclusively in beta cells., Conclusions/interpretation: This study is an important step towards identifying key molecular factors involved in development of the human fetal endocrine pancreas.
- Published
- 2008
- Full Text
- View/download PDF
47. Expression of the hepatic specific V1 messenger ribonucleic acid of the human growth hormone receptor gene is regulated by hepatic nuclear factor (HNF)-4alpha2 and HNF-4alpha8.
- Author
-
Goodyer CG, Rhani Z, and Zheng H
- Subjects
- Adolescent, Adult, Aged, Base Sequence, Binding Sites genetics, Blotting, Western, Cell Line, Child, Chromatin Immunoprecipitation, Electrophoretic Mobility Shift Assay, Hepatocyte Nuclear Factor 4 genetics, Hepatocyte Nuclear Factor 4 metabolism, Humans, Liver embryology, Liver growth & development, Middle Aged, Molecular Sequence Data, Mutagenesis, Site-Directed, Promoter Regions, Genetic genetics, Protein Binding, Protein Isoforms genetics, Protein Isoforms metabolism, Protein Isoforms physiology, RNA, Messenger genetics, Response Elements genetics, Reverse Transcriptase Polymerase Chain Reaction, Sequence Homology, Nucleic Acid, Carrier Proteins genetics, Gene Expression Regulation, Developmental, Hepatocyte Nuclear Factor 4 physiology, Liver metabolism, RNA, Messenger metabolism
- Abstract
Human (h) GH plays an essential role in growth and metabolism, and its effectiveness is modulated by the availability of its specific receptor [hGH receptor (hGHR)] on target cells. The hGHR gene has a complex 5'-regulatory region containing multiple first exons. Seven are clustered within two small regions: V2,V3,V9 (module A) and V1,V4,V7,V8 (module B). Module A-derived mRNAs are ubiquitously expressed whereas those from module B are only found in postnatal liver, suggesting developmental- and liver-specific regulation of module B hGHR gene expression. To characterize the elements regulating module B activity, we studied a 1.8-kb promoter of the highest expressing exon in liver, V1. This promoter was repressed in transfection assays; however, either 5'- or 3'-deletions relieved this, suggesting the presence of multiple negative regulatory elements. Six putative hepatic nuclear factor 4 (HNF-4) response elements were identified. We determined that HNF-4alpha is developmentally regulated in the human liver: HNF-4alpha2 and HNF-4alpha8 are expressed in fetal hepatocytes but only HNF-4alpha2 is expressed in postnatal liver. Transient transfection assays demonstrated that HNF-4alpha2 and HNF-4alpha8 have a similar dual effect on V1 transcription: activation via site 1 in the proximal promoter and repression through site 6, approximately 1.7 kb upstream. EMSA/electrophoretic mobility supershift assays and chromatin immunoprecipitation analyses confirmed these two sites are bound by HNF-4alpha. Based on these data, we speculate there are multiple regions working together to repress the expression of V1 hGHR transcripts in tissues other than the normal postnatal liver, and that HNF-4alpha is a good candidate for regulating V1 hGHR expression in the human hepatocyte.
- Published
- 2008
- Full Text
- View/download PDF
48. SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas.
- Author
-
Waha A, Koch A, Hartmann W, Milde U, Felsberg J, Hübner A, Mikeska T, Goodyer CG, Sörensen N, Lindberg I, Wiestler OD, Pietsch T, and Waha A
- Subjects
- Azacitidine analogs & derivatives, Azacitidine pharmacology, Base Sequence, Cell Line, Tumor, Cell Proliferation, Cerebellar Neoplasms genetics, CpG Islands genetics, DNA Modification Methylases antagonists & inhibitors, Decitabine, Down-Regulation drug effects, Down-Regulation genetics, Enzyme Inhibitors pharmacology, Gene Expression Profiling, Gene Expression Regulation, Neoplastic drug effects, Humans, Medulloblastoma genetics, Molecular Sequence Data, Reverse Transcriptase Polymerase Chain Reaction, Sequence Analysis, DNA, Transcription, Genetic drug effects, Cerebellar Neoplasms pathology, DNA Methylation, Medulloblastoma pathology, Neuroendocrine Secretory Protein 7B2 genetics
- Abstract
In a genome-wide screen using differential methylation hybridization (DMH), we have identified a CpG island within the 5' region and untranslated first exon of the secretory granule neuroendocrine protein 1 gene (SGNE1/7B2) that showed hypermethylation in medulloblastomas compared to fetal cerebellum. Bisulfite sequencing and combined bisulfite restriction assay were performed to confirm the methylation status of this CpG island in primary medulloblastomas and medulloblastoma cell lines. Hypermethylation was detected in 16/23 (70%) biopsies and 7/8 (87%) medulloblastoma cell lines, but not in non-neoplastic fetal (n=8) cerebellum. Expression of SGNE1 was investigated by semi-quantitative competitive reverse transcription-polymerase chain reaction and found to be significantly downregulated or absent in all, but one primary medulloblastomas and all cell lines compared to fetal cerebellum. After treatment of medulloblastoma cell lines with 5-aza-2'-deoxycytidine, transcription of SGNE1 was restored. No mutation was found in the coding region of SGNE1 by single-strand conformation polymorphism analysis. Reintroduction of SGNE1 into the medulloblastoma cell line D283Med led to a significant growth suppression and reduced colony formation. In summary, we have identified SGNE1 as a novel epigenetically silenced gene in medulloblastomas. Its frequent inactivation, as well as its inhibitory effect on tumor cell proliferation and focus formation strongly argues for a significant role in medulloblastoma development.
- Published
- 2007
- Full Text
- View/download PDF
49. Expression of c-Kit receptor tyrosine kinase and effect on beta-cell development in the human fetal pancreas.
- Author
-
Li J, Quirt J, Do HQ, Lyte K, Fellows F, Goodyer CG, and Wang R
- Subjects
- Cell Differentiation genetics, Cell Survival genetics, Cells, Cultured, Homeodomain Proteins genetics, Humans, Insulin genetics, Proto-Oncogene Proteins c-kit metabolism, RNA Interference, Trans-Activators genetics, Transfection, Gene Expression Regulation, Developmental physiology, Insulin-Secreting Cells cytology, Pancreas embryology, Proto-Oncogene Proteins c-kit genetics
- Abstract
The receptor, c-Kit, and its ligand, stem cell factor (SCF), are critical for hematopoietic stem cell differentiation and have been implicated in the development, function, and survival of rodent islets. Previously, we reported that exogenous SCF treatments of cultured human fetal (14-16 wk fetal age) islet-epithelial clusters enhanced islet cell differentiation and proliferation (Li J, Goodyer CG, Fellows F, Wang R. Int J Biochem Cell Biol 38: 961-972, 2006). In the present study, we examined the expression pattern of c-Kit in early to midgestation human fetal pancreata and the relevance of c-Kit receptor tyrosine kinase for insulin gene expression and beta-cell survival. c-Kit is expressed in the intact pancreas in a cell-specific manner, with a significant decrease in immunoreactivity in the duct regions from 8 to 21 wk fetal age, paralleled by a significant increase in expression within endocrine regions. These c-Kit-positive cells are highly proliferative and show frequent coexpression with insulin and glucagon. Treatment of islet-epithelial clusters with anti-ACK45 antibody stimulates c-Kit phosphorylation paralleled by a significant increase in PDX-1 and insulin expression, increased cell proliferation, and reduced beta-cell death. In contrast, transient transfection with c-Kit siRNA results in a three- to fourfold decrease in c-Kit, PDX-1, and insulin expression and decreased cell proliferation. This study describes important changes in the distribution and dynamics of c-Kit-expressing cells during human fetal pancreatic neogenesis, suggesting that c-Kit may be a marker for human pancreatic islet progenitor cells. Functional analysis of the c-Kit receptor tyrosine kinase provides evidence that phosphorylation of c-Kit receptor may be involved in mediating early beta-cell differentiation and survival.
- Published
- 2007
- Full Text
- View/download PDF
50. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
- Author
-
Koch A, Hrychyk A, Hartmann W, Waha A, Mikeska T, Waha A, Schüller U, Sörensen N, Berthold F, Goodyer CG, Wiestler OD, Birchmeier W, Behrens J, and Pietsch T
- Subjects
- Adolescent, Adult, Axin Protein, Base Sequence, Blotting, Western, Cell Line, Tumor, Cerebellum embryology, Cerebellum growth & development, Cerebellum metabolism, Child, Child, Preschool, Cytoskeletal Proteins metabolism, DNA Methylation, DNA Mutational Analysis, Female, Gene Expression Profiling, Humans, Infant, Male, Medulloblastoma genetics, Medulloblastoma metabolism, Middle Aged, RNA, Messenger genetics, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction genetics, Signal Transduction physiology, TCF Transcription Factors genetics, Wnt1 Protein genetics, Wnt1 Protein metabolism, Cytoskeletal Proteins genetics, Medulloblastoma pathology, Mutation, TCF Transcription Factors metabolism, Transcription, Genetic
- Abstract
Medulloblastomas (MBs) represent the most common malignant brain tumors in children. Most MBs develop sporadically in the cerebellum, but their incidence is highly elevated in patients with familial adenomatous polyposis coli. These patients carry germline mutations in the APC tumor suppressor gene. APC is part of a multiprotein complex involved in the Wnt signaling pathway that controls the stability of beta-catenin, the central effector in this cascade. Previous genetic studies in MBs have identified mutations in genes coding for beta-catenin and its partners, APC and AXIN1, which cause activation of Wnt signaling. The pathway is negatively controlled by the tumor suppressor AXIN2 (Conductin), a scaffold protein of this signaling complex. To investigate whether alterations in AXIN2 may also be involved in the pathogenesis of sporadic MBs, we performed a mutational screening of the AXIN2 gene in 116 MB biopsy samples and 11 MB cell lines using single-strand conformation polymorphism and sequencing analysis. One MB displayed a somatic, tumor-specific 2 bp insertion in exon 5, leading to carboxy-terminal truncation of the AXIN2 protein. This tumor biopsy showed nuclear accumulation of beta-catenin protein, indicating an activation of Wnt signaling. In 2 further MB biopsies, mutations were identified in exon 5 (Glu408Lys) and exon 8 (Ser738Phe) of the AXIN2 gene, which are due to predicted germline mutations and rare polymorphisms. mRNA expression analysis in 22 MBs revealed reduced expression of AXIN2 mRNA compared to 8 fetal cerebellar tissues. Promoter hypermethylation could be ruled out as a major cause for transcriptional silencing by bisulfite sequencing. To study the functional role of AXIN2 in MBs, wild-type AXIN2 was overexpressed in MB cell lines in which the Wnt signaling pathway was activated by Wnt-3a. In this assay, AXIN2 inhibited Wnt signaling demonstrated in luciferase reporter assays. In contrast, overexpression of mutated AXIN2 with a deleted C-terminal DIX-domain resulted in an activation of the Wnt signaling pathway. These findings indicate that mutations of AXIN2 can lead to an oncogenic activation of the Wnt pathway in MBs., ((c) 2007 Wiley-Liss, Inc.)
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.